1. Central statistical monitoring of investigator-led clinical trials in oncology

   • Marc Buyse
   • Laura Trotta
   • Junichi Sakamoto

   Invited Review Article 23 June 2020 Pages: 1207 - 1214

   

2. Recent advances of the regulation roles of MicroRNA in glioblastoma

   • Chengrui Yan
   • Xiangyi Kong
   • Yuanli Zhao

   Review Article 29 April 2020 Pages: 1215 - 1222

3. Practical guidance for the evaluation of disease progression and the decision to change treatment in patients with advanced gastric cancer receiving chemotherapy

   • Satoru Iwasa
   • Toshihiro Kudo
   • Taroh Satoh

   Review Article Open access 29 April 2020 Pages: 1223 - 1232

   

4. Correction to: Practical guidance for the evaluation of disease progression and the decision to change treatment in patients with advanced gastric cancer receiving chemotherapy

   • Satoru Iwasa
   • Toshihiro Kudo
   • Taroh Satoh

   Correction 22 June 2020 Pages: 1233 - 1233

5. Implementation of a molecular tumor board at a regional level to improve access to targeted therapy

   • Héloïse Bourien
   • Alexandra Lespagnol
   • Julien Edeline

   Original Article 25 March 2020 Pages: 1234 - 1241

   

6. Performance of three prognostic models in critically ill patients with cancer: a prospective study

   • Frank D. Martos-Benítez
   • Hilev Larrondo-Muguercia
   • Jorge L. Martínez-Alfonso

   Original Article 24 March 2020 Pages: 1242 - 1249

   

7. A phase II study of adaptive two-step intensity-modulated radiation therapy (IMRT) with chemotherapy for loco-regionally advanced nasopharyngeal cancer (JCOG1015)

   • Yasumasa Nishimura
   • Satoshi Ishikura
   • Masahiro Hiraoka

   Original Article 27 March 2020 Pages: 1250 - 1259

   

8. Dynamic prediction of cancer-specific survival for primary hypopharyngeal squamous cell carcinoma

   • Zhongyang Lin
   • Hanqing Lin
   • Chang Lin

   Original Article 07 April 2020 Pages: 1260 - 1269

   

9. Effect of tumor burden and growth rate on treatment outcomes of nivolumab in head and neck cancer

   • C. Suzuki
   • N. Kiyota
   • H. Minami

   Original Article 10 April 2020 Pages: 1270 - 1277

   

10. Urinalysis by combination of the dipstick test and urine protein–creatinine ratio (UPCR) assessment can prevent unnecessary lenvatinib interruption in patients with thyroid cancer

    • Chie Masaki
    • Kiminori Sugino
    • Koichi Ito

    Original Article 28 April 2020 Pages: 1278 - 1284

    

11. Phase II study of S-1-based sequential combination chemotherapy including oxaliplatin plus bevacizumab and irinotecan with or without cetuximab for metastatic colorectal cancer: the SOBIC trial

    • Yoshihiko Nakamoto
    • Masafumi Noda
    • Naohiro Tomita

    Original Article 21 March 2020 Pages: 1285 - 1290

    

12. Phase II study of 5-fluorouracil–leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802)

    • Takashi Ohta
    • Takeshi Kato
    • Taroh Satoh

    Original Article 26 March 2020 Pages: 1291 - 1298

    

13. An inflammation index-based prediction of treatment response to neoadjuvant chemoradiotherapy for rectal mucinous adenocarcinoma

    • Yanwu Sun
    • Zhekun Huang
    • Pan Chi

    Original Article 09 April 2020 Pages: 1299 - 1307

    

14. Serum LOX-1 is a novel prognostic biomarker of colorectal cancer

    • Chiyo Nakashima-Nakasuga
    • Shoichi Hazama
    • Hiroaki Nagano

    Original Article 11 April 2020 Pages: 1308 - 1317

    

15. Postoperative C-reactive protein/albumin ratio is a biomarker of risk of recurrence and need for adjuvant chemotherapy for stage III colorectal cancer

    • Hiroya Matsuoka
    • Koji Ando
    • Masaki Mori

    Original Article 11 April 2020 Pages: 1318 - 1326

    

16. High hepatitis B virus screening rate among patients receiving systemic anticancer treatment in Japan

    • S. Yazaki
    • T. Yamauchi
    • T. Higashi

    Original Article 21 March 2020 Pages: 1327 - 1333

    

17. Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma

    • Zhuozhen Lyu
    • Mingze Ma
    • Tao Li

    Original Article 28 April 2020 Pages: 1334 - 1345

    

18. ACO2 and ANPEP as novel prognostic markers for gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas

    • Ziru Liu
    • Zhulin Yang
    • Yuan Yuan

    Original Article 05 April 2020 Pages: 1346 - 1355

    

19. Construction and validation of a novel prognostic nomogram for patients with sarcomatoid renal cell carcinoma: a SEER-based study

    • Guangdong Hou
    • Xi’an Li
    • Jianlin Yuan

    Original Article 02 May 2020 Pages: 1356 - 1363

    

20. A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tables

    • Makito Miyake
    • Hideyasu Matsuyama
    • Nishinihon Uro-oncology Extensive Collaboration group

    Original Article 30 March 2020 Pages: 1364 - 1376

    

21. Risk factors and oncological outcomes of urethral recurrence in male patients with muscle invasive bladder cancer after radical cystectomy combined with urinary diversion: a propensity score-matched case control study

    • Zichuan Yao
    • Yunzhong Jiang
    • Song Bai

    Original Article 21 April 2020 Pages: 1377 - 1384

    

22. Atypical oncologic failure after laparoscopic and robot-assisted radical cystectomy at a single institution

    • Masashi Kubota
    • Hidetoshi Kokubun
    • Mutsushi Kawakita

    Original Article 18 April 2020 Pages: 1385 - 1392

    

23. External validation of the "optimal PSA follow-up schedule after radical prostatectomy” in a new cohort

    • Yoshinori Yanai
    • Kazuhiro Matsumoto
    • Mototsugu Oya

    Original Article 13 April 2020 Pages: 1393 - 1397

24. Small-volume lymph node involvement and biochemical recurrence after robot-assisted radical prostatectomy with extended lymph node dissection in prostate cancer

    • Shuichi Morizane
    • Masashi Honda
    • Atsushi Takenaka

    Original Article 24 April 2020 Pages: 1398 - 1404

    

25. Can serial evaluation of serum SCC-Ag-level predict tumor recurrence and patient survival in squamous-cell carcinoma of uterine cervix treated with definitive chemoradiotherapy? A multi-institutional analysis

    • Kyu Hye Choi
    • Mina Yu
    • Jong Hoon Lee

    Original Article 27 March 2020 Pages: 1405 - 1411

    

26. Surgical outcomes of early-stage primary vaginal nonsquamous cell carcinoma

    • Hidetaka Nomura
    • Yuji Tanaka
    • Nobuhiro Takeshima

    Original Article 27 March 2020 Pages: 1412 - 1417

    

27. Clinical significance of thermal detection of soft-tissue tumors

    • Akiyoshi Shimatani
    • Manabu Hoshi
    • Hiroaki Nakamura

    Original Article 21 March 2020 Pages: 1418 - 1424

    

28. Management and outcome of pediatric Wilms tumor with malignant inferior Vena cava thrombus: largest cohort of single-center experience

    • Moatasem Elayadi
    • Mahmoud Hammad
    • Wael Zekri

    Original Article 05 April 2020 Pages: 1425 - 1431

    

29. Utility of whole brain radiation therapy for leptomeningeal carcinomatosis

    • Yasuhiro Hirano
    • Kei Konishi
    • Yasuo Ejima

    Original Article 09 April 2020 Pages: 1432 - 1439